Obstructive sleep apnea (OSA) is the most common respiratory sleep disorder and present the occurrence of a minimum of five interruptions in breathing and/or the decrease in ventilation for more than 50%, minimum duration of 10 seconds, during one hour of sleeping (apnea/hypopnea index -AHI) with the existence of daytime and nighttime difficulties.The diagnosis of sleep-disordered breathing is made by polysomnography testing in specialized centers. Depending on the type and severity of the disorder different therapeutic modalities are available:hygienic-dietary regimen and lifestyle, use of oral appliances (OA), noninvasive ventilation with continuous positive airway pressure (CPAP)through a mask during sleep time and surgical approach to upper airways. CPAP is a gold standard in sleep apnea syndrome treatment, especially in severe forms of OSA.A therapy of choice for mild to moderate obstructive sleep apnea and at the same time an alternative treatment for CPAP intolerance are oral appliances.A mandibular advancement device and a tongue-retaining device are in use. Simplicity, portability, lack of noise, independence from a power source, and potentially lower cost, bring potential advantages over CPAP.By increasing the volume of upper airways, the number of obstructive breathing events is being significantly reduced, and arterial oxygen saturation is being improved. A close cooperation and surveillance by medical doctor and dentist is required, from the correct choice and drafting of oral appliance, through initial patient's accommodation to treatment, to long-term follow-up of therapeutic effect in sleep medicine laboratories.
L’ESTRANGE PR, BATTAGEL JM, HARKNESS B, SPRATLEY MH, NOLAN PJ, JORGENSEN GI. A method of studying adaptive changes of the oropharynx to variation in mandibular position in patients with obstructive sleep apnoea. Journal of Oral Rehabilitation. 1996;23(10):699–711.
2.
Barnes M, McEvoy RD, Banks S, Tarquinio N, Murray CG, Vowles N, et al. Efficacy of Positive Airway Pressure and Oral Appliance in Mild to Moderate Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 2004;170(6):656–64.
3.
Lazard DS, Blumen M, Lévy P, Chauvin P, Fragny D, Buchet I, et al. The Tongue-Retaining Device: Efficacy and Side Effects in Obstructive Sleep Apnea Syndrome. Journal of Clinical Sleep Medicine. 2009;05(05):431–8.
4.
Naismith SL, Winter VR, Hickie IB, Cistulli PA. Effect of Oral Appliance Therapy on Neurobehavioral Functioning In Obstructive Sleep Apnea: A Randomized Controlled Trial. Journal of Clinical Sleep Medicine. 2005;01(04):374–80.
5.
MEHTA A, QIAN J, PETOCZ P, DARENDELILER MA, CISTULLI PA. A Randomized, Controlled Study of a Mandibular Advancement Splint for Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 2001;163(6):1457–61.
6.
Gotsopoulos H, Chen C, Qian J, Cistulli PA. Oral Appliance Therapy Improves Symptoms in Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 2002;166(5):743–8.
7.
Pitsis AJ, Darendeliler MA, Gotsopoulos H, Petocz P, Cistulli PA. Effect of Vertical Dimension on Efficacy of Oral Appliance Therapy in Obstructive Sleep Apnea. American Journal of Respiratory and Critical Care Medicine. 2002;166(6):860–4.
8.
Gotsopoulos H, Kelly JJ, Cistulli PA. Oral Appliance Therapy Reduces Blood Pressure in Obstructive Sleep Apnea: a Randomized, Controlled Trial. Sleep. 2004;27(5):934–41.
9.
Yoshida K. Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. 2006;19:61–6.
10.
Ferguson KA, Ono T, Lowe AA, al-Majed S, Love LL, Fleetham JA. A short-term controlled trial of an adjustable oral appliance for the treatment of mild to moderate obstructive sleep apnoea. Thorax. 1997;52(4):362–8.
11.
de Almeida FR, Cistulli P, Fleury B, Gagnadoux F. Mandibular advancement devices. Obstructive Sleep Apnoea. 2015. p. 253–65.
12.
FRITSCH KM, ISELI A, RUSSI EW, BLOCH KE. Side Effects of Mandibular Advancement Devices for Sleep Apnea Treatment. American Journal of Respiratory and Critical Care Medicine. 2001;164(5):813–8.
13.
Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral Appliances for Snoring and Obstructive Sleep Apnea: A Review. Sleep. 2006;29(2):244–62.
14.
Pantin CC, Hillman DR, Tennant M. Dental Side Effects of an Oral Device to Treat Snoring and Obstructive Sleep Apnea. Sleep. 1999;22(2):237–40.
15.
Marklund M, Sahlin C, Stenlund H, Persson M, Franklin KA. Mandibular Advancement Device in Patients With Obstructive Sleep Apnea. Chest. 2001;120(1):162–9.
16.
Marklund M. Orthodontic side-effects of mandibular advancement devices during treatment of snoring and sleep apnoea. The European Journal of Orthodontics. 2001;23(2):135–44.
17.
Bondemark L. Craniomandibular status and function in patients with habitual snoring and obstructive sleep apnoea after nocturnal treatment with a mandibular advancement splint: a 2-year follow-up. The European Journal of Orthodontics. 2000;22(1):53–60.
18.
Rose EC, Staats R, Virchow C, Jonas IE. Occlusal and Skeletal Effects of an Oral Appliance in the Treatment of Obstructive Sleep Apnea. Chest. 2002;122(3):871–7.
FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.
21.
Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive Sleep Apnea, Hypertension, and Their Interaction on Arterial Stiffness and Heart Remodeling. Chest. 2007;131(5):1379–86.
22.
Kopitovic I, Trajanovic N, Prodic S, Drvenica MJ, Ilic M, Kuruc V, et al. The Serbian version of the Epworth Sleepiness Scale. Sleep and Breathing. 2011;15(4):775–80.
23.
Tkacova R, Dorkova Z. Clinical presentations of OSA in adults. Sleep Apnoea. 2010. p. 86–103.
24.
Lavie L. Oxidative Stress—A Unifying Paradigm in Obstructive Sleep Apnea and Comorbidities. Progress in Cardiovascular Diseases. 2009;51(4):303–12.
25.
Suzuki YJ, Jain V, Park AM, Day RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radical Biology and Medicine. 2006;40(10):1683–92.
26.
Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. Obstructive Sleep Apnea and Risk of Cardiovascular Events and All-Cause Mortality: A Decade-Long Historical Cohort Study. PLoS Medicine. 11(2):e1001599.
27.
Gami AS, Olson EJ, Shen WK, Wright RS, Ballman KV, Hodge DO, et al. Obstructive Sleep Apnea and the Risk of Sudden Cardiac Death. Journal of the American College of Cardiology. 2013;62(7):610–6.
28.
Kopitović I, Jovančević-Drvenica M, Vukoja M, Okiljević Z. Poremećaji disanja tokom spavanja. 2011;11(1):310–5.
29.
Punjabi NM. Sleep-Disordered Breathing, Glucose Intolerance, and Insulin Resistance: The Sleep Heart Health Study. American Journal of Epidemiology. 2004;160(6):521–30.
30.
Kryger M, Roth T, Dement W. Principles and practice of sleep medicine. 2011.
31.
Kopitović I. Respiratorni poremećaji tokom spavanja. 2011.
32.
McNicholas WT, Verbraecken J, Marin JM. Sleep disorders in COPD: the forgotten dimension. European Respiratory Review. 2013;22(129):365–75.
33.
Durgan DJ, Bryan RM. Cerebrovascular Consequences of Obstructive Sleep Apnea. Journal of the American Heart Association. 2012;1(4).
34.
Chen YH, Keller JK, Kang JH, Hsieh HJ, Lin HC. Obstructive Sleep Apnea and the Subsequent Risk of Depressive Disorder: A Population-Based Follow-up Study. Journal of Clinical Sleep Medicine. 2013;09(05):417–23.
35.
Randerath WJ, Verbraecken J, Andreas S, Bettega G, Boudewyns A, Hamans E, et al. Non-CPAP therapies in obstructive sleep apnoea. European Respiratory Journal. 2011;37(5):1000–28.
36.
Cistulli PA, Gotsopoulos H, Marklund M, Lowe AA. Treatment of snoring and obstructive sleep apnea with mandibular repositioning appliances. Sleep Medicine Reviews. 2004;8(6):443–57.
37.
Sleep Apnea. Progress in Respiratory Research. 2006.
38.
Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep and Breathing. 2007;11(1):1–22.
39.
Isono S, Tanaka A, Tagaito Y, Sho Y, Nishino T. Pharyngeal Patency in Response to Advancement of the Mandible in Obese Anesthetized Persons . Anesthesiology. 1997;87(5):1055–62.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.